TRANSMEDICS GROUP INC (TMDX) Forecast, Price Target & Analyst Ratings

NASDAQ:TMDX • US89377M1099

Current stock price

100.695 USD
+0.29 (+0.29%)
At close:
100.5 USD
-0.19 (-0.19%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TRANSMEDICS GROUP INC (TMDX).

Forecast Snapshot

Consensus Price Target

Price Target
$164.50
+ 63.36% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
$0.62
Revenue Estimate
176.13M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
83.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$164.50
Upside
+ 63.36%
From current price of $100.70 to mean target of $164.50, Based on 20 analyst forecasts
Low
$131.30
Median
$171.36
High
$199.50

Price Target Revisions

1 Month
10.46%
3 Months
10.52%

Price Target Summary

20 Wall Street analysts provided a forecast for the next 12 months for TMDX. The average price target is 164.5 USD. This implies a price increase of 63.36% is expected in the next year compared to the current price of 100.695.
The average price target has been revised upward by 10.52% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

TMDX Current Analyst RatingTMDX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

TMDX Historical Analyst RatingsTMDX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
83.00%
TMDX was analyzed by 20 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about TMDX.
In the previous month the buy percentage consensus was at a similar level.
TMDX was analyzed by 20 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-09StifelMaintains Hold -> Hold
2026-02-25NeedhamMaintains Buy -> Buy
2026-02-25OppenheimerMaintains Outperform -> Outperform
2026-02-25Evercore ISI GroupMaintains Outperform -> Outperform
2026-02-25JP MorganMaintains Neutral -> Neutral
2026-02-25Piper SandlerMaintains Overweight -> Overweight
2025-12-17Canaccord GenuityMaintains Buy -> Buy
2025-12-08NeedhamMaintains Buy -> Buy
2025-12-02Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2025-10-30Canaccord GenuityMaintains Buy -> Buy
2025-10-30Piper SandlerMaintains Overweight -> Overweight
2025-10-23NeedhamUpgrade Hold -> Buy
2025-10-14Canaccord GenuityMaintains Buy -> Buy
2025-10-13JefferiesInitiate Buy
2025-09-16Evercore ISI GroupInitiate Outperform
2025-09-04StifelInitiate Hold
2025-08-25NeedhamReiterate Hold -> Hold
2025-08-01Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2025-07-15Canaccord GenuityMaintains Buy -> Buy
2025-06-17NeedhamReiterate Hold -> Hold
2025-06-17OppenheimerMaintains Outperform -> Outperform
2025-06-04Piper SandlerReiterate Overweight -> Overweight
2025-06-03NeedhamReiterate Hold -> Hold
2025-05-09OppenheimerMaintains Outperform -> Outperform
2025-05-09Piper SandlerReiterate Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
$0.62
Revenue Estimate
176.13M
Revenue Q2Q
22.71%
EPS Q2Q
-11.41%
Number of Analysts
13

Next Earnings Revisions

Revenue (1 Month)
-0.58%
Revenue (3 Months)
0.92%
EPS (1 Month)
-6.62%
EPS (3 Months)
-12.77%

Next Earnings Summary

TMDX is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is 0.62 USD and the consensus revenue estimate is 176.13M USD.
The next earnings revenue estimate has been revised upward by 0.92% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2029

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
TMDX revenue by date.TMDX revenue by date.
241.623M
158.53%		441.54M
82.74%		605.494M
37.13%		753.89M
24.51%		895M
18.72%		1.034B
15.53%		1.179B
14.02%
EBITDA
YoY % growth
TMDX ebitda by date.TMDX ebitda by date.
8.662M
130.98%		57.254M
560.98%		135.768M
137.13%		171.38M
26.23%		238.17M
38.97%		324.59M
36.29%		487.97M
50.33%
EBIT
YoY % growth
TMDX ebit by date.TMDX ebit by date.
485K
101.54%		37.496M
7,631.13%		108.583M
189.59%		115.67M
6.53%		184.06M
59.13%		248.17M
34.83%		352.51M
42.04%
Operating Margin
TMDX operating margin by date.TMDX operating margin by date.
0.20%8.49%17.93%15.34%20.57%24.00%29.90%
EPS
YoY % growth
TMDX eps by date.TMDX eps by date.
-0.77
38.40%		1.01
231.17%		2.81
178.22%		2.61
-6.95%		3.76
43.80%		4.68
24.48%		4.43
-5.42%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.62
-11.41%		0.75
-18.79%		0.58
-11.63%		0.67
25.84%		0.92
47.96%		1.00
33.98%		0.91
55.30%		0.99
47.76%
Revenue
Q2Q % growth		176.13M
22.71%		192.96M
22.62%		180.7M
25.64%		202.28M
25.82%		212.98M
20.92%		228.76M
18.55%		212.28M
17.48%		231.42M
14.41%
EBITDA
Q2Q % growth		41.045M
22.23%		47.96M
-2.98%		42.86M
-0.36%		49.98M
3.14%		53.152M
29.50%		59.211M
23.46%		54.784M
27.82%		60.313M
20.67%
EBIT
Q2Q % growth		26.883M
-2.04%		33.163M
-9.31%		25.313M
8.64%		30.436M
43.07%		46.432M
72.72%		50.49M
52.25%		44.517M
75.87%		47.256M
55.26%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

TMDX Yearly Revenue VS EstimatesTMDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
TMDX Yearly EPS VS EstimatesTMDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2 4 -4 -6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
18.54%
EPS Next 5 Year
12.03%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
19.07%
Revenue Next 5 Year
17.79%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
45.75%
EBIT Next 5 Year
46.88%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

TRANSMEDICS GROUP INC / TMDX Forecast FAQ

What do analysts expect the price target to be for TRANSMEDICS GROUP INC (TMDX)?

20 analysts have analysed TMDX and the average price target is 164.5 USD. This implies a price increase of 63.36% is expected in the next year compared to the current price of 100.695.

Can you provide the upcoming earnings date for TRANSMEDICS GROUP INC?

TRANSMEDICS GROUP INC (TMDX) will report earnings on 2026-05-06.

Can you provide the consensus estimates for TRANSMEDICS GROUP INC next earnings?

The consensus EPS estimate for the next earnings of TRANSMEDICS GROUP INC (TMDX) is 0.62 USD and the consensus revenue estimate is 176.13M USD.

What is the number of analysts for TMDX stock?

The number of analysts covering TRANSMEDICS GROUP INC (TMDX) is 20.